• Logo
  • SBMUJournals

Evaluation and comparing rectum and bladder's clinical complications in pelvis radiotherapy in order to treat prostate cancer by using custom block and MLC for three- dimensional conformal radiotherapy

Sadegh Sabzi, Mohsen Bakhshandeh, Mohammad Houshyari, Nezhat Shakeri, Ali Jabbary Arfaee
545

Views

PDF

Abstract

       Ionization radiation caused to incidence of complications in the exposed organs. In prostate radiotherapy, rectum and bladder have been radiated unwantedly and indicated some complications during and after treatment. The purpose of present study is to consider and to compare clinical complications of rectum and bladder in custom block and MLC for 3- D conformal radiotherapy, in order to determine if both treatments differ with respect to creating radiation protection, subsequently in the incidence of complications. In this respect, 72 patients with prostate cancer classified into two arms, above 60 years without the history of previous radiotherapy, hormone therapy and surgery, were selected randomly in October 2014. In one arm, patients were treated with block 3- D conformal radiotherapy, and in second arm with MLC outbound technique for 3- D radiotherapy. Rectal and bladder clinical complications were recorded before, during (at the end of 10 treatment sessions), 3 and 6 months after treatment then compared based on tables (RTOG/ LENT).Obtained results showed that patients had a significant difference in such complications as urinary frequency after 10 treatment sessions, 3 months after treatment (p<0.02 and p<0.04, respectively)   Also, patients had a significant difference in regard to dysuria at the end of treatment (p<0.02). In both arms, patients had a significant difference in constipation after 30 sessions also at the end of treatment (p<0.02, p<0.02, respectively).In comparing different grades of complications based on RTOG/ LENT tables, it was not observed a significant difference between patients' complications in both arms.


Keywords

clinical complications , conformal radiotherapy , prostate cancer

References

Eugene H Huang, Alan Pollack, Larry Levy, George Starkschall, Lei Dong, Isaac Rosen, Deborah A Kuban Late rectal toxicity: dose volume effects of conformal radiotherapy for prostate cancer International Journal of Radiation Oncology*Biology*Physics, Volume 54, Issue 5, 1 December 2002, Pages 131–1321.

W. Robert Lee, et al. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: Further evidence for a significant dose effect; International Journal of Radiation Oncology*Biology*Physics, Volume 35, Issue 2, 1 May 1996, Pages 251–257.

A.C. Hartford, A. Niemierko, J.A. Adams, et al. Conformal irradiation of the prostate: Estimating long-term rectal bleeding risk using dose-volume histograms. Int J Radiat Oncol BiolPhys, 36 (1996), pp. 721–730.

M.W. Skwarchuk, A. Jackson, M.J. Zelefsky, et al. Late rectal toxicity after conformal radiotherapy of prostate cancer (I): Multivariate analysis and dose-response. Int J RadiatOncolBiolPhys, 47 (2000), pp. 103–113.

A. Pollack, G.K. Zagars, L.G. Smith, et al.Preliminary results of a randomized radiotherapy dose-escalation study comparing 70 Gy with 78 Gy for prostate cancer. J ClinOncol, 18 (2000), pp. 3904–3911.

A. Pollack, G.K. Zagars, G. Starkschall, et al. Conventional vs. conformal radiotherapy for prostate cancer: preliminaryresults of dosimetry and acute toxicity. Int J RadiatOncolBiolPhys, 34 (1996), pp. 555–564.

T.E. Schultheiss, R. Lee, M. Hunt, et al. Late GI and GU complications in the treatment of prostate cancer. Int J RadiatOncolBiolPhys, 37 (1997), pp. 3–11.

L.J. Boersma, M. van den Brink, A.M. Bruce, et al. Estimation of the incidence of late bladder and rectum complications after high-dose conformal radiotherapy for prostate cancer using dose-volume histograms. Int J RadiatOncolBiolPhys, 41 (1998), pp. 83–92.

Fuccio L , Guido A, Andreyev HJN. Management of intestinal complication in patients with pelvic radiation disease . clin Gastroenterol Hepatol 2012; 10:1326-34.

SHadad AK,Sullivan FJ, Martin JD, Egan L J . Gastrointestinal radiation hn jury : prevention and treatment . World J Gasstroenterol 2013 ;19:199-208.

Doorr W, HGendry JH, Consequential lat effects in normal tissues . Radiotherapy oncol 2001;61:223-31.

B. EscheJ. Crook, N. Futter; Effect of pelvic radiotherapy for prostate cancer on bowel, bladder, and sexual function: The patient's perspective. Adult urology,Volume 47, Issue 3, March 1996, Pages 387–394.

BaharBal Talarli, VildanAlpan, SaitOkkan, SedatKoca; Comparison of multileaf collimator and customized blocks for 3-D conformal radiotherapy of prostate cancer with six-field technique. Turkish Journal of Cancer, 2006, Volume 36, Number 3, Page(s) 126-132.

Mark R Storey, Alan Pollack, GunarZagars, Lewis Smith, John Antolak, et al. Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial; International Journal of Radiation Oncology*Biology*Physics; Volume 48, Issue 3, 1 October 2000, Pages 635–642.

Estimation of the Incidence of Late Bladder and Rectum Complications After High-Dose (70–78 Gy) Conformal Radiotherapy for Prostate Cancer, Using Dose–Volume Histograms, 1998, International Journal of Radiation Oncology* Biology* Physics.

A.L. Hanlon, T.E. Schultheiss, M.A. Hunt, Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales. Int J RadiatOncolBiolPhys, 38 (1997), pp. 59–63.

J.D. Cox, J. Stetz, T.F. Pajak, Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J RadiatOncolBiolPhys, 31 (1995), pp. 1341–1346.




DOI: https://doi.org/10.22037/jps.v7i4.11682

Refbacks

  • There are currently no refbacks.